Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya. 2012

Wiam A Alashek, and Christopher W McIntyre, and Maarten W Taal
Department of Renal Medicine, Derby Hospitals NHS Foundation Trust, Derby, UK.

BACKGROUND The extent and the distribution of end stage kidney disease (ESKD) in Libya have not been reported despite provision of dialysis over 4 decades. This study aimed to develop the first comprehensive description of the epidemiology of dialysis-treated ESKD in Libya. METHODS Structured demographic and clinical data were obtained regarding all adult patients treated at all maintenance dialysis facilities (n=39) in Libya from May to September 2009. Subsequently data were collected prospectively on all new patients who started dialysis from September 2009 to August 2010. Population estimates were obtained from the Libyan national statistics department. The age and gender breakdown of the population in each region was obtained from mid-2009 population estimates based on 2006 census data. RESULTS The prevalence of dialysis-treated ESKD was 624 per million population (pmp). 85% of prevalent patients were aged <65 years and 58% were male. The prevalence of ESKD varied considerably with age with a peak at 55-64 years (2475 pmp for males; 2197 pmp for females). The annual incidence rate was 282 pmp with some regional variation and a substantially higher rate in the South (617 pmp). The most common cause of ESKD among prevalent and incident patients was diabetes. Other important causes were glomerulonephritis, hypertensive nephropathy and congenital or hereditary diseases. CONCLUSIONS Libya has a relatively high prevalence and incidence of dialysis-treated ESKD. As the country prepares to redevelop its healthcare system it is hoped that these data will guide strategies for the prevention of CKD and planning for the provision of renal replacement therapy.

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008002 Libya A country in northern Africa, bordering the Mediterranean Sea, between Egypt, Tunisia, and Algeria, having southern border with Chad, Niger, and Sudan. Its capital is Tripoli.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009393 Nephritis Inflammation of any part of the KIDNEY. Nephritides
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses

Related Publications

Wiam A Alashek, and Christopher W McIntyre, and Maarten W Taal
August 2014, International urology and nephrology,
Wiam A Alashek, and Christopher W McIntyre, and Maarten W Taal
April 2015, Nephrology (Carlton, Vic.),
Wiam A Alashek, and Christopher W McIntyre, and Maarten W Taal
April 2020, Nederlands tijdschrift voor geneeskunde,
Wiam A Alashek, and Christopher W McIntyre, and Maarten W Taal
November 2015, Health affairs (Project Hope),
Wiam A Alashek, and Christopher W McIntyre, and Maarten W Taal
March 2021, Seminars in vascular surgery,
Wiam A Alashek, and Christopher W McIntyre, and Maarten W Taal
November 2020, Advances in chronic kidney disease,
Wiam A Alashek, and Christopher W McIntyre, and Maarten W Taal
June 2014, Journal of renal care,
Wiam A Alashek, and Christopher W McIntyre, and Maarten W Taal
May 2016, The Cochrane database of systematic reviews,
Wiam A Alashek, and Christopher W McIntyre, and Maarten W Taal
May 2021, JAMA internal medicine,
Wiam A Alashek, and Christopher W McIntyre, and Maarten W Taal
July 2010, Zhonghua nei ke za zhi,
Copied contents to your clipboard!